Search - tctmd.com

Displaying 101 - 120 of 247

Sort: Relevancy | Date

News Daily News

More Missing MIs, Late Complications Blamed on COVID-19 in Italy and California

Shelley Wood

May 22, 2020

News Daily News

‘Terrible’ Spike in Cardiac Arrest Deaths During Lombardy’s COVID-19 Surge

Shelley Wood

May 01, 2020

News Daily News

FDA: Abbott Recalls NC Trek RX and NC Traveler Coronary Catheters

Shelley Wood

February 24, 2020

News Daily News

ACS After TAVR a Unique Condition With Poor Prognosis

Todd Neale

February 05, 2020

News Daily News

FDA Gives Rivaroxaban Another VTE-Related Indication

Todd Neale

October 14, 2019

News Daily News

FDA: Class I Recall for Medtronic’s 6-Fr Sherpa NX Guide Catheter

Michael O'Riordan

October 09, 2019

News Conference News ESC 2019

AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD

Todd Neale

September 02, 2019

News Conference News ESC 2019

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Shelley Wood

August 22, 2019

News Daily News

Meta-analysis Supports Surgical LAA Occlusion During Cardiac Surgery, but Flaws Found

Todd Neale

August 16, 2019

News Daily News

Bleeding, Myocardial Injury Are Key Drivers of Deaths After Noncardiac Surgery

Michael O'Riordan

July 29, 2019

News Daily News

Unplanned Readmission Within 6 Months Affects 25% of PCI Patients in the US

L.A. McKeown

March 28, 2019

Presentation ISET 2019

Comparing Hospital Utilization Outcomes (Catheter-Based vs Systemic Therapy) for Submassive & Massive Pulmonary Embolism

Presenter: Jack Hannallah

January 30, 2019

News Daily News

Opioid Use Does Not Impart Higher In-Hospital Mortality for Cardiac Surgery Patients

Caitlin E. Cox

December 06, 2018

News Conference News AHA 2018

Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF

Todd Neale

November 11, 2018

News Daily News

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

Todd Neale

October 12, 2018

Presentation TCT Abstracts Posters 2018

Pulmonary Embolism Severity Index (PESI) is a Predictor of Mid-Term Death After Mechano-Pharmacological Treatment of Acute Pulmonary Embolism

Presenter: D. Vasilev

September 25, 2018

News Conference News TCT 2018

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

Todd Neale

September 24, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Three: Intravascular Imaging and Anticoagulation

Shelley Wood

September 24, 2018

Presentation TCT 2018

Case 3 From Saudi Arabia: STEMI - Air Shock and Embolism

Presenter: Jorge Cortes Lawrenz, Juan F. Granada, Oscar A. Mendiz, Carlos Cabrera Arroyo, Carlos D Calderas, Anibal A. Damonte, Nabeel Ismaeil

September 24, 2018

Presentation TCT 2018

TCT-59: Outcomes of Catheter-Directed Thrombolysis versus Standard Medical Therapy in Patients Admitted to Intensive Care Units with Submassive Pulmonary Embolism

Presenter: Shao-Liang Chen, Mitchell Weinberg, Stephen D'Auria

September 21, 2018

Advertisement

More Missing MIs, Late Complications Blamed on COVID-19 in Italy and California

‘Terrible’ Spike in Cardiac Arrest Deaths During Lombardy’s COVID-19 Surge

FDA: Abbott Recalls NC Trek RX and NC Traveler Coronary Catheters

ACS After TAVR a Unique Condition With Poor Prognosis

FDA Gives Rivaroxaban Another VTE-Related Indication

FDA: Class I Recall for Medtronic’s 6-Fr Sherpa NX Guide Catheter

AFIRE Supports Rivaroxaban Monotherapy in A-fib Patients With Stable CAD

ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More

Meta-analysis Supports Surgical LAA Occlusion During Cardiac Surgery, but Flaws Found

Bleeding, Myocardial Injury Are Key Drivers of Deaths After Noncardiac Surgery

Unplanned Readmission Within 6 Months Affects 25% of PCI Patients in the US

Comparing Hospital Utilization Outcomes (Catheter-Based vs Systemic Therapy) for Submassive & Massive Pulmonary Embolism

Opioid Use Does Not Impart Higher In-Hospital Mortality for Cardiac Surgery Patients

Rivaroxaban Lowers Thromboembolic Risk in HF Patients: COMMANDER HF

FDA Approves Rivaroxaban for CV Event Reduction in CAD and PAD Patients

Pulmonary Embolism Severity Index (PESI) is a Predictor of Mid-Term Death After Mechano-Pharmacological Treatment of Acute Pulmonary Embolism

OAC-ALONE: No Clear Answer for Best Therapy Beyond 1 Year After PCI in A-fib Patients

TCT 2018, Day Three: Intravascular Imaging and Anticoagulation

Case 3 From Saudi Arabia: STEMI - Air Shock and Embolism

TCT-59: Outcomes of Catheter-Directed Thrombolysis versus Standard Medical Therapy in Patients Admitted to Intensive Care Units with Submassive Pulmonary Embolism

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content